Advertisement

Medical marijuana laws and pregnancy: implications for public health policy

      Although there is much to learn yet about the effects of prenatal marijuana use on pregnancy and child outcome, there is enough evidence to suggest that marijuana, contrary to popular perception, is not a harmless drug, especially when used during pregnancy. Consequently, the public health system has a responsibility to educate physicians and the public about the impact of marijuana on pregnancy and to discourage the use of medical marijuana by pregnant women or women considering pregnancy.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American College of Obstetricians and Gynecologists
        Marijuana use during pregnancy and lactation. ACOG Committee Opinion no. 637.
        Obstet Gynecol. 2015; 126: 234-238
        • Mehmedic Z.
        • Chandra S.
        • Slade D.
        • et al.
        Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008.
        J Forens Sci. 2010; 55: 1209-1217
        • Jones J.T.
        • Baldwin A.
        • Shu I.
        A comparison of meconium screening outcomes as an indicator of the impact of state-level relaxation of marijuana policy.
        Drug Alcohol Depend. 2015; 156: e104-e105
        • Varner M.W.
        • Silver R.M.
        • Hogue C.J.R.
        Association between stillbirth and illicit drug use and smoking during pregnancy.
        Obstet Gynecol. 2014; 123: 113-125
        • Hayatbakhsh M.R.
        • Flenady V.J.
        • Gibbons K.S.
        • et al.
        Birth outcomes associated with cannabis use before and during pregnancy.
        Pediatr Res. 2012; 71: 215-219
        • Hurda Y.L.
        • Wanga X.
        • Anderson V.
        • Beck O.
        • Minkoff H.
        • Dow-Edwards D.Y.L.
        Marijuana impairs growth in mid-gestation fetuses.
        Neurotoxicol Teratol. 2005; 27: 221-229
        • El Marroun H.
        • Tiemeier H.
        • Steegers E.A.P.
        • et al.
        Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R study.
        J Am Acad Child Adolesc Psycyiatry. 2009; 48: 1173-1181
        • English D.R.
        • Hulse G.K.
        • Milne E.
        • Holman C.D.
        • Bower C.I.
        Maternal cannabis use and birth weight: a meta-analysis.
        Addiction. 1997; 92: 1553-1560
        • Trezza V.
        • Cuomo V.
        • Louk J.
        • Vanderschuren M.J.
        Cannabis and the developing brain: insights from behavior.
        Eur J Pharmacol. 2008; 585: 441-452
        • Harbison R.D.
        • Mantilla-Plata B.
        Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol.
        J Pharmacol Exp Ther. 1972; 180: 446-453
        • Hutchings D.E.
        • Martin B.R.
        • Gamagaris Z.
        • Miller N.
        • Fico T.
        Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats.
        Life Sci. 1989; 44: 697-701
        • Pertwee R.G.
        Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
        Addict Biol. 2008; 13: 147-159
        • Psychoyos D.
        • Vinod K.Y.
        Marijuana, Spice “herbal high,” and early neural development: implications for rescheduling and legalization.
        Drug Test Anal. 2013; 5: 27-45
        • vanGelder M.M.
        • Reefhuis J.
        • Caton A.R.
        • Werler M.M.
        • Druschel C.M.
        • Roeleveld N.
        Maternal periconceptional illicit drug use and the risk of congenital malformations.
        Epidemiology. 2008; 20: 60-66
        • Mulder J.
        • Aguado T.
        • Keimpema E.
        • et al.
        Endocannabinoid signaling controls pyramidal cell specification and long range axon patterning.
        Proc Natl Acad Sci USA. 2008; 105: 8760-8765
        • Hernandez M.
        • Berrendero F.
        • Suarez I.
        • et al.
        Cannabinoid CB(1) receptors colocalize with tyrosin hydroxlase in cultured fetal mesencephalic neurons and the action increases the levels of this enzyme.
        Brain Res. 2000; 857: 56-65
      1. Harkany T, Keimpema E, Barabas K, Mulder J. Endocannabinoid functions controlling neuronal specification during brain development. Mol Cell Endocrinol 286:S84-90.

        • Harkany T.
        • Guzman M.
        • Galve-Roperch I.
        • Berghuis P.
        • Devi L.A.
        • Mackie K.
        The emerging functions of endocannabinoid signaling during CNS development.
        Trends Pharmacol Sci. 2007; 28: 83-92
        • Galve-Ropeth I.
        • Aguado T.
        • Rueda D.
        • Velasco G.
        • Guzman M.
        Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development.
        Curr Pharm Des. 2006; 12: 2319-2325
        • Guzman M.
        • Sanchez C.
        • Galve-Ropeth I.
        Control of the cell survival/death decision by cannabinoids.
        J Mol Med. 2001; 78: 613-625
        • Bernard C.
        • Milh M.
        • Morozoy Y.M.
        • Ben-Ari Y.
        • Freund T.F.
        • Gozlan H.
        Altering cannabinoid signaling during development disrupts neuronal activity.
        Proc Natl Acad Sci USA. 2005; 102: 9388-9393
        • Wang X.
        • Dow-Edwards D.
        • Anderson V.
        • Minkoff H.
        • Hurd Y.L.
        In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus.
        Biol Psychiatry. 2004; 56: 909-915
        • Fried P.A.
        • Makin J.E.
        Neonatal behavioral correlates of prenatal exposure to marijuana, cigarettes, and alcohol in a low risk population.
        Neurotoxicol Teratol. 1987; 9: 1-7
        • Coles C.D.
        • Platzman K.A.
        • Smith I.
        • James M.E.
        • Falek A.
        Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status.
        Neurotoxicol Teratol. 1992; 14: 23-33
        • Maraes Barros M.C.
        • Guinsburg R.
        • Araujo Peres C.
        Exposure to marijuana during pregnancy alters neurobehavior in the early neonatal period.
        J Pediatr. 2006; 149: 781-787
        • Scher M.S.
        • Richardson G.A.
        • Coble P.A.
        • Day N.L.
        • Stoffer D.S.
        The effects of prenatal alcohol and marijuana exposure: disturbances in neonatal sleep cycling and arousal.
        Pediatr Res. 1988; 24: 101-105
        • Richardson G.A.
        • Day N.L.
        • Goldschmidt L.
        Prenatal alcohol, marijuana and tobacco use: infant mental and motor development.
        Neurotoxicol Teratol. 1995; 17: 479-489
        • Dreher M.C.
        • Nugent K.
        • Hudgins R.
        Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study.
        Pediatrics. 1994; 93: 254-260
        • Goldschmidt L.
        • Richardson G.A.
        • Willford J.
        • Day N.L.
        Prenatal marijuana exposure and intelligence test performance at age 6.
        J Am Acad Child Adolesc Psychiatry. 2008; 47: 254-263
        • Jastak S.
        • Wilkinson G.S.
        Manual for the Wide Range Achievement Test, revised.
        Jastak Associates, Wilmington (DE)1984
        • Goldschmidt L.
        • Richardson G.A.
        • Cornelius M.D.
        • Day N.L.
        Prenatal marijuana and alcohol exposure and academic achievement at age 10.
        Neurotoxicol Teratol. 2004; 26: 521-532
        • Richardson G.A.
        • Ryan C.
        • Willford J.
        • Day N.L.
        • Goldschmidt L.
        Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at ten years.
        Neurotoxicol Teratol. 2002; 24: 309-320
        • Goldschmidt L.
        • Day N.L.
        • Richardson G.A.
        Effects of prenatal marijuana exposure on child behavior problems at age 10.
        Neurotoxicol Teratol. 2000; 22: 325-336
        • Day N.L.
        • Leech S.L.
        • Goldschmidt L.
        The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning.
        Neurotoxicol Teratol. 2011; 33: 129-136
        • Fried P.A.
        • Smith A.M.
        A literature review of the consequences of prenatal marihuana exposure: an emerging theme of a deficiency in aspects of executive function.
        Neurotoxcol Teratol. 2001; 23: 1-11
        • Smith A.M.
        • Longo C.A.
        • Fried P.A.
        • Hogan M.J.
        • Cameron I.
        Effects of prenatal marihuana on visuospatial working memory: an fMRI study in young adults.
        Neurotoxciol Teratol. 2006; 28: 286-295
      2. ProCon.org. (March 14, 2016). 24 legal medical marijuana states and DC. Available at: http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881. Accessed June 4, 2016.

      3. Oregon Health Authority. Public Health Division, Medical Marijuana Dispensary Program. Information bulletin 2015-04. Sept. 10, 2015, page 3. Available at: www.oregon.gov/oha/mmj/Bulletins/Informational%20Bulletin%202015-04%20Early%20Retail%20Sales.pdf.

      4. Colorado Department of Health. Available at: www.colorado.gov/pacific/sites/default/files/MJ_RMEP_Pregnancy-Breastfeeding-Clinical-Guidelines.pdf. Accessed June 4, 2016.

      5. American Medical Association. Marijuana use in pregnancy. Policy Statement, Nov. 16, 2015. Available at: www.ama-assn.org. Accessed June 18, 2016.

      Linked Article